Oximes: Metabolic activation and structure-allergenic activity relationships

Journal of Medicinal Chemistry

Volumn 51, Issue 8, 2008, Pages 2541-2550

  Bergström, Moa Andresen ^a   Andersson, Sofia I ^a   Broo, Kerstin ^a   Luthman, Kristina ^a   Karlberg, Ann Therese ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLCYCLOHEX 2 ENONE OXIME; 2,3 DIMETHYLCYCLOHEX 2 ENONE OXIME; 3 METHYLCYCLOHEX 2 ENONE OXIME; BENZALDOXIME; CYCLOHEX 2 ENONE OXIME; GLUTATHIONE; HAPTEN; HEX 4 EN 3 ONE OXIME; OXIME; PROHAPTEN;

ALLERGENICITY; ARTICLE; CHEMICAL BOND; DRUG ACTIVITY; DRUG SYNTHESIS; IN VITRO STUDY; METABOLIC ACTIVATION; SKIN SENSITIZATION; SKIN TOXICITY; STRUCTURE ACTIVITY RELATION;

ALLERGENS; ANIMALS; BIOTRANSFORMATION; FEMALE; GLUTATHIONE; MICE; MICE, INBRED CBA; MICROSOMES, LIVER; OXIMES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 43049150746     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm701092n     Document Type: Article

References (47)

1. Kalgutkar, A. S.; Gardner, I.; Obach, R. S.; Shaffer, C. L.; Callegari, E.; Henne, K. R.; Mutlib, A. E.; Dalvie, D. K.; Lee, J. S.; Nakai, Y.; O'Donnell, J. P.; Boer, J.; Harriman, S. P. A comprehensive listing of bioactivation pathways of organic functional groups. Curr. Drug Metab. 2005, 6, 161-225.
2. Guengerich, F. P. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol. 2001, 14, 611-650.
3. Smith, C. K.; Hotchkiss, S. A. M. Xenobiotics as skin sensitizers: Metabolic activation and detoxification, and protein-binding mechanisms. Allergic contact dermatitis: Chemical and metabolic mechanisms; Taylor and Francis: London, 2001: pp 119-205.
4. Rustemeyer, T.; van Hoogstraten, I. M. W.; von Blomberg, B. M. E.; Scheper, R. J. Mechanisms in allergic contact dermatitis. In Contact Dermatitis. 4th ed.; Frosch, P. J., Menné, T., Lepoittevin, J. P., Eds.; Springer: Berlin, Heidelberg, 2006: pp 11-43.
5. Kimber, I.; Basketter, D. A.; Gerberick, G. F.; Dearman, R. J. Allergic contact dermatitis. Int. Immunopharm. 2000, 2, 201-211.
6. Nielsen, N. H.; Linneberg, A.; Menne, T.; Madsen, F.; Frolund, L.; Dirksen, A.; Jorgensen, T. Allergic contact sensitization in an adult Danish population: Two cross-sectional surveys eight years apart (the Copenhagen Allergy Study). Acta Derm. Venereol. 2001, 81, 31-4.
7. Metsavainio, A. S.; Utter, A.; Stenberg, B.; Liden, C.; Meding, B.; Svensson, A. Skin allergy and hypersensitivity surveyed in a Swedish study. Lakartidningen 2006, 103, 3075-8.
8. Gerberick, G. F.; Ryan, C. A.; Dearman, R. J.; Kimber, I. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals. Methods 2007, 41, 54-60.
9. EU, Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Off. J. Eur. Union 2006, L 396, 1-849.
10. EU, Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. Off. J. Eur. Union 2003, L 66, 26-35.
11. Smith, C. K.; Hotchkiss, S. A. M. Allergic contact dermatitis to small molecule xenohiotics. Allergic contact dermatitis: Chemical and metabolic mechanisms; Taylor and Francis: London, 2001: pp 1-17.
12. Bergstrom, M. A.; Ott, H.; Carlsson, A.; Neis, M.; Zwadlo-Klarwasser, G.; Jonsson, C. A.; Merk, H. F.; Karlberg, A. T.; Baron, J. M. A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J. Invest. Dermatol. 2007, 127, 1145-53.
13. Bergstrom, M. A.; Luthman, K.; Nilsson, J. L. G.; Karlberg, A.-T. Conjugated dienes as prohaptens in contact allergy: In vivo and in vitro studies of structure-activity relationships, sensitizing capacity, and metabolic activation. Chem. Res. Toxicol. 2006, 19, 760-769.
14. Bergstrom, M. A.; Luthman, K.; Karlberg, A.-T. Metabolic epoxidation of an α,β-unsaturated oxime generates sensitizers of extreme potency. Are nitroso intermediates responsible. Chem. Res. Toxicol. 2007, 20, 927-936.
15. Karlberg, A. T. Contact allergy to colophony. Chemical identifications of allergens, sensitization experiments and clinical experiences. Acta Derm. Venereol. Suppl. (Stockholm) 1988, 139, 1-13.
16. Hagvall, L.; Backtorp, C.; Svensson, S.; Nyman, G.; Borje, A.; Karlberg, A. T. Fragrance compound geraniol forms contact allergens on air exposure. Identification and quantification of oxidation products and effect on skin sensitization. Chem. Res. Toxicol. 2007, 20, 807-814.
17. Skold, M.; Borje, A.; Harambasic, E.; Karlberg, A. T. Contact allergens formed on air exposure of linalool. Identification and quantification of primary and secondary oxidation products and the effect on skin sensitization. Chem. Res. Toxicol. 2004, 17, 1697-705.
18. Doss, G. A.; Baillie, T. A. Addressing metabolic activation as an integral component of drug design. Drug Metab. Rev. 2006, 38, 641-649.
19. Evans, D. C.; Watt, A. P.; Nicoll-Griffith, D. A.; Baillie, T. A. Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem. Res. Toxicol. 2004, 17, 3-16.
20. Dieckhaus, C. M.; Fernandez-Metzler, C. L.; King, R.; Krolikowski, P. H.; Baillie, T. A. Negative ion tandem mass spectrometry for the detection of glutathione conjugates. Chem. Res. Toxicol. 2005, 18, 630-8.
21. Gerberick, G. F.; Vassallo, J. D.; Bailey, R. E.; Chaney, J. G.; Morrall, S. W.; Lepoittevin, J. P. Development of a peptide reactivity assay for screening contact allergens. Toxicol. Sci. 2004, 81, 332-343.
22. Aptula, A. O.; Patlewicz, G.; Roberts, D. W.; Schultz, T. W. Non-enzymatic glutathione reactivity and in vitro toxicity: A non-animal approach to skin sensitization. Toxicol. In Vitro 2006, 20, 239-247.
23. Natsch, A.; Gfeller, H.; Rothaupt, M.; Ellis, G. Utility and limitations of a peptide reactivity assay to predict fragrance allergens in vitro. Toxicol. In Vitro 2007, 21, 1220-1226.
24. Chen, Q. H.; Rao, P. N. P.; Knaus, E. E. Synthesis and biological evaluation of a novel class of rofecoxib analogues us dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs). Bioorg. Med. Chem. 2006, 14, 7898-7909.
25. Kataoka, H.; Horiyama, S.; Yamaki, M.; Oku, H.; Ishiguro, K.; Katagi, T.; Takayama, M.; Semma, M.; Ito, Y. Anti-inflammatory and anti-allergic activities of hydroxylamine and related compounds. Biol. Pharm. Bull. 2002, 25, 1436-1441.
26. Jokanovic, M.; Stojiljkovic, M. P. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning. Eur. J. Pharmacol. 2006, 553, 10-17.
27. Hainzl, D.; Loureiro, A. I.; Parada, A.; Soares-Da-Silva, P. Metabolism of 10,11-dihydro-10-hydroxyimino-5H-dibenz[b,f]azepine-5- carboxamide, a potent anti-epileptic drug. Xenobiotica 2002, 32, 131-140.
28. Mutlib, A. E.; Chen, S. Y.; Espina, R. J.; Shockeor, J.; Prakash, S. R.; Gan, L. S. P450-mediated metabolism of 1-[3-(aminomethyl)phenyl]-N-[3- fluoro-2′-(methylsulfonyl)-[1,1′-biphenyl]-4-y1]-3-(trifluoromethyl) -1H-pyrazole-5-carboxamide (DPC 423) and its analogues to aldoximes. Characterization of glutathione conjugates of postulated intermediates derived from aldoximes. Chem. Res. Toxicol. 2002, 15, 63-75.
29. Nilsson, A. M.; Bergstrom, M. A.; Luthman, K.; Nilsson, J. L.; Karlberg, A. T. An α,β-unsaturated oxime identified as a strong contact allergen. Indications of antigen formation via several pathways. Food Chem. Toxicol. 2005, 43, 1627-36.
30. Zaidlewicz, M.; Uzarewicz, I. G. Reduction of conjugated cyclohexenome oximes with aluminium hydride. Pol. J. Chem. 1988, 62, 143-150.
31. Chibiryaev, A. M.; Denisov, A. Y.; Pyshnyi, D. V.; Tkachev, A. V. Direct C-nitration of cyclic α,β-unsaturated oximes under the action of sodium nitrite and acetic acid in methanol. Russ. Chem. Bull. 2001, 50, 1410-1418.
32. Uzarewicz, A.; Dresler, R. Reaction of cyclic allylic acefates with aliphatic alcohols in the presence of cerium(III) chloride. Pol. J. Chem. 1998, 72, 1921-1930.
33. Zeller, W. E.; Zeller, L. S.; Hansen, J. F. CMR spectra of N-oxygenated pyrazoles I. 3,5-Dialkyl- and 3-alkyl-5-phenyl-4-oxo-4H- pyrazole 1,2-dioxides. Heterocycles 1999, 51, 145-155.
34. Kimber, I.; Hilton, J.; Dearman, R. J.; Gerberick, G. F.; Ryan, C. A.; Basketter, D. A.; Scholes, E. W.; Ladies, G. S.; Loveless, S. E.; House, R. V.; Guy, A. An international evaluation of the murine local lymph node assay and comparison of modified procedures. Toxicology 1995, 103, 63-73.
35. Andersen, K. E.; Maibach, H. I. Contact allergy predictive tests in guinea pigs; Karger: Basel, 1985: Vol. 14.
36. Mekenyan, O.; Dimitrov, S.; Serafimova, R.; Thompson, E.; Kotov, S.; Dimitrova, N.; Walker, J. D. Identification of the structural requirements for mutagenicity by incorporating molecular flexibility and metabolic activation of chemicals I: TA100 model. Chem. Res. Toxicol. 2004, 17, 753-66.
37. Serafimova, R.; Todorov, M.; Pavlov, T.; Kotov, S.; Jacob, E.; Aptula, A.; Mekenyan, O. Identification of the structural requirements for mutagencitiy, by incorporating molecular flexibility and metabolic activation of chemicals. II. General Ames mutagenicity model. Chem. Res. Toxicol. 200720, 662-76.
38. Vohr, H.-W.; Ahr, H. J. The local lymph node assay being too sensitive. Arch. Toxicol. 2005, 79, 721-28.
39. Smith, C. K.; Hotchkiss, S. A. M. Enzymes and pathways of xenobiotic metabolism in skin. Allergic contact dermatitis: Chemical and metabolic mechanisms; Taylor and Francis: London, 2001: pp 89-117.
40. Gerberick, G. F.; Ryan, C. A.; Kern, P. S.; Dearman, R. J.; Kimber, I.; Patlewicz, G. Y.; Basketter, D. A. A chemical dataset for evaluation of alternative approaches to skin-sensitization testing. Contact Dermatitis 2004, 50, 274-88.
41. Parmar, D.; Burka, L. T. Metabolism and disposition of cyclohexanone oxime in male F344 rats. Drug Metab. Dispos. 1991, 19, 1101-1107.
42. Nilsson, A. M.; Gäfvert, E.; Salvador, L.; Luthman, K.; Bruze, M.; Gruvberger, B.; Nilsson, J. L. G.; Karlberg, A. T. Mechanism of the antigen formation of carvone and related α,β-unsaturated ketones. Contact Dermatitis 2001, 44, 347-356.
43. Warnhoff, E. W.; Martin, D. G.; Johnson, W. S. 2-Chloro-2- methylcyclohexane and 2-methyl-2-cyclohexenone. Org. Synth. 1957, 37, 8-12.
44. Corey, E. J.; Melvin, L. S.; Haslanger, M. F. Novel α-alkylation of α,β-epoxy ketones. Tetrahedron Lett. 1975, 3117-3120.
45. Basketter, D. A.; Lea, L. J.; Dickens, A.; Briggs, D.; Pate, I.; Dearman, R. J.; Kimber, I. A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. J. Appl. Toxicol. 1999, 19, 261-266.
46. European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC). Contact sensitization: classification according to potency. Technical report no. 87; ECETOC: Brussels, Belgium, 2003.
47. Kimber, I.; Basketter, D. A.; Butler, M.; Garner, A.; Garrigue, J. L.; Gerberick, G. F.; Newsome, C.; Steiling, W.; Vohr, H. W. Classification of contact allergens according to potency: proposals. Food Chem. Toxicol. 2003, 41, 1799-809.